Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evolver is a life science technology company that provides a fully automated, high-throughput continuous culture system designed for microbiology and synthetic biology research. Spun out of the Khalil Lab at Boston University, the company's core technology is a modular hardware platform that allows researchers to precisely control and monitor microbial growth in real-time across hundreds of independent cultures. The system is primarily utilized for directed evolution, metabolic engineering, and the optimization of microbial strains for industrial and therapeutic applications. By automating complex fluidics and environmental controls, Evolver enables the rapid generation of high-quality longitudinal data that was previously labor-intensive or impossible to collect.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evolver.